article thumbnail

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies

Fierce Healthcare

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies agliadkovskaya Thu, 05/04/2023 - 14:30

article thumbnail

Healthcare costs will grow 7% next year, PwC finds

Health Care Dive

Providers are expected to seek rate increases from payers as they struggle with labor costs, while health plans will face pressure from increased pharmaceutical expenses.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Medtronic Expands AI-Driven Partnership with Cosmo Pharmaceuticals to Transform Endoscopy

HIT Consultant

What You Should Know: – Medtronic announced an expanded AI partnership with Cosmo Pharmaceuticals NV , a pharmaceutical company, to further advance AI-powered solutions in the medical field. Cosmo Pharmaceuticals remains the exclusive manufacturer of the platform.

article thumbnail

European Union Pharmaceutical Package: A Summary

Healthcare ECONOMIST

Today I’m turning this post over to some of my FTI colleagues in Europe ( Antoine Mialhe , Katja Murray and Valeria Fagone among others) who helped summarize the Reform of the EU pharmaceutical legislation that the European Union (EU) adopted on April 26, 2023. A more detailed analysis is in the PDF link below.

article thumbnail

Diffusion of pharmaceuticals and the patient’s influence

Healthcare ECONOMIST

Through what mechanisms are patients and physicians made aware of new pharmaceuticals and decide to prescribe them. It is well known that physician peer networks often help share information about new pharmaceuticals including clinical information as well as the providers own experience using the new treatment.

article thumbnail

Health spending spikes in Massachusetts amid high drug expenses, unprecedented patient cost sharing, regulator warns

Fierce Healthcare

Pharmaceutical costs, non-claims payments and outpatient care fueled “unchecked” healthcare spending in Massachusetts that's increasingly being felt by its residents, according to new findings from | The Bay State's healthcare cost growth benchmark program is calling for policy action after a report showed per-person health spending well (..)

article thumbnail

Relative importance of pharmaceuticals on health outcomes: 1990-2015

Healthcare ECONOMIST

Is it new surgical techniques, better diagnostics, improved medical devices, or new pharmaceuticals? Based on physicians responses, across all 8 diseases , pharmaceuticals had the largest impact on health. Across all 8 diseases 56% of the relative value came from pharmaceuticals. Clearly public health initiatives (e.g.,